Position in DXCM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$202
-$112 QoQ
Shares Held
3
-40.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#956
of 966 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Seneschal Advisors, LLC holds $52,826 across 9 Medical Devices names. DXCM ranks #9 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
545 | $49,452 | |
| 2 | MDT |
Medtronic plc
|
9 | $704 | |
| 3 | SYK |
Stryker Corp
|
2 | $629 | |
| 4 | EW |
Edwards Lifesciences Corp
|
6 | $542 | |
| 5 | STE |
STERIS plc
|
2 | $421 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
5 | $320 | |
| 7 | BSX |
Boston Scientific Corp
|
7 | $298 | |
| 8 | ZBH |
Zimmer Biomet Holdings, Inc.
|
3 | $258 |
All Filings in DXCM
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $202 | 3 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $314 | 5 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $132 | 2 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $201 | 3 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||